Lee Shapiro
CIK 1213350 · Chief Financial Officer · last filed 2025-01-08
Lee Shapiro is a Chief Financial Officer who has filed 81 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for CLOV, was dated Jan 8, 2025. Across all open-market trades the lifetime net is −$31.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.8M across reported positions. 42 SEC filings were submitted jointly with ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LVGO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2401 COMMERCE DR
LIBERTYVILLE, IL 60048
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLOV | Director | 598,622 | $4.71 | $2.82M | $248.1K | 6 | 2025-01-08 |
| CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOVW) Delisted | Director | — | $2.02 | — | $0 | 1 | 2021-04-06 |
| Livongo Health, Inc. (LVGO) Delisted | Chief Financial Officer | 0 | — | — | -$17.53M | 17 | 2020-10-30 |
| TIVITY HEALTH, INC. (TVTY) Delisted | Director | 40,304 | $32.50 | $1.31M | $120.9K | 5 | 2020-02-28 |
| TIVITY HEALTH, INC. (HWAY) Delisted | Director | 20,203 | $38.05 | $768.7K | $74.5K | 4 | 2016-11-07 |
| Veradigm Inc. (MDRX) Delisted | President and Secretary | 702,488 | $6.81 | $4.78M | -$14.05M | 34 | 2012-11-27 |
Recent Filings
81 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-08 | CLOV | Grant (A) | +60,975 | $0 | EDGAR |
| 2024-01-05 | CLOV | Grant (A) | +206,185 | $200.0K | EDGAR |
| 2023-01-05 | CLOV | Grant (A) | +176,991 | $0 | EDGAR |
| 2022-09-26 | CLOV | Mixed | +47,371 | $0 | EDGAR |
| 2022-03-15 | CLOV | Buy (P) | +80,000 | $248.1K | EDGAR |
| 2022-01-11 | CLOV | Exer (M) | +27,100 | $0 | EDGAR |
| 2021-04-06 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOVW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-30 | Livongo Health, Inc. (LVGO) Delisted | Mixed | −4,471,391 | $0 | EDGAR |
| 2020-09-16 | Livongo Health, Inc. (LVGO) Delisted | Sell (S) | −23 | -$2.9K | EDGAR |
| 2020-09-15 | Livongo Health, Inc. (LVGO) Delisted | Other (J) | −850,442 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.